Thomas Groner, DPM
Podiatrist · Niles, OHNPI 1073510301
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $138,874 of the $193,294 with a category attached, or 71.8%. Smith+Nephew accounts for 97.2% of it on its own, with 20 other manufacturers making up the rest. Among podiatrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 378 payments — averaging $511.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$188K
- Osiris Therapeutics Inc.$4K
- Organogenesis Inc.$384
- Amgen$216
- Misonix Inc$161
- Convatec Inc.$94
- plus $778 from 15 others
What the payments were for
- Consulting fees$17,1339%
- Speaking & faculty fees$138,87472%
- Travel & lodging$29,07415%
- Food & beverage$8,2134%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 314 | $187,794 |
| Osiris Therapeutics Inc. | 11 | $3,867 |
| Organogenesis Inc. | 12 | $384 |
| Amgen | 2 | $216 |
| Misonix Inc | 2 | $161 |
| Convatec Inc. | 4 | $94 |
| Cashflow Solutions, LLC | 6 | $92 |
| Pacira Pharmaceuticals Incorporated | 1 | $86 |
| Kerecis Limited | 2 | $85 |
| KCI USA, Inc. | 4 | $76 |
| Paratek Pharmaceuticals, Inc. | 4 | $66 |
| Integra Lifesciences Corporation | 2 | $65 |
| Solventum Corporation | 3 | $59 |
| 3M Company | 1 | $55 |
| AbbVie(2 entities) | 3 | $50 |
| Medtronic | 1 | $41 |
| Nevro Corp. | 2 | $37 |
| B. Braun Medical Inc. | 1 | $26 |
| Globus Medical | 1 | $17 |
| Merck | 1 | $11 |
| Reprise Biomedical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Grafix$153,246
- Stravix$115,159
- GRAFIX PL$109,502
- Grafix XC$76,200
- STRAVIX PL$44,838
- Oasis$44,790
- GrafixPL$20,421
- NA$18,469
- STRAVIX MESH$8,728
- Grafix PRIME$8,119
- Grafix CORE$8,119
- Grafix PL PRIME$8,119
- OASIS MICRO$4,055
- REGRANEX$1,080
- Iodosorb Ointment 40g USA$334
- PICO$162
- KRYSTEXXA$123
How this compares
$193,294 in reported general payments places this provider in the 95th percentile of 397 podiatrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 48 | $427 |
| Methylprednisolone | 40 | $256 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Niles
- Mark HardyAvon$2.1M
- Lawrence DidomenicoBoardman$1.1M
- Ralph NapolitanoNew Albany$494K
- Michael MaierCleveland$120K
- Eric StortsLondon$101K
- Daniel LoganGahanna$83K
- Howard KimmelBrookpark$67K
- James HayesCleveland$31K
- Nathan RossiCleveland$31K
- Macaira DymentPowell$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.